Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Triokinase/FMN Cyclase: A Bifunctional Enzyme Linking Metabolism, Stress Responses and Disease.

Created on 12 Nov 2026

Authors

João Meireles Ribeiro, Fernando Martín-Ruiz, José Carlos Cameselle

Published in

Biology. Volume 15. Issue 19. Oct 03, 2026. Epub Oct 03, 2026.

Abstract

Triokinase/FMN cyclase (TKFC) is a bifunctional enzyme that catalyzes both ATP-dependent triose phosphorylation and the formation of riboflavin 4',5'-cyclic phosphate (cFMN) from FAD, thereby linking fructose and flavin metabolism through a single protein. Structural modeling supports a model of TKFC as a conformationally dynamic homodimer in which interacting K and L domains cooperate through composite intersubunit active sites to support both kinase and cyclase reactions. Beyond its classical role in fructose metabolism, TKFC has emerged as a determinant of fructose-derived carbon partitioning and has been implicated in nutrient sensing, oxidative stress adaptation, innate immunity, ferroptosis and several inherited human disorders. Recent biochemical and analytical studies have renewed interest in cFMN as a bona fide metabolite and provide evidence consistent with cFMN synthesis and degradation, while its physiological turnover remains to be established. Here, we review the historical development, structural organization, catalytic mechanisms and expanding biological functions of TKFC, highlighting its links with intermediary metabolism, cellular stress adaptation and human disease.

PMID:
42883437
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement